Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan plus hydrochlorothiazide in stage 1 or high-normal arterial hypertension with organ damage
2008-000804-10Phase 4Active
- Sponsor
- University of Naples Federico II
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of valsartan and hydrochlorothiazide in hypertension (HTN) and essential hypertension, sponsored by University of Naples Federico II. Primary endpoints: Normalization of arterial blood pressure and Improvement of organ damage. Started May 2009; status: active.
02
Drugs
valsartanhydrochlorothiazide
03
Conditions
hypertension (HTN)essential hypertension
Beyond the preview
Go deeper on 2008-000804-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000804-10.